Department of Urology, University of Verona, Verona, Italy; Urology Institute, University of Southern California, Los Angeles, CA, USA.
Department of Urology, University of Verona, Verona, Italy.
Eur Urol. 2019 Sep;76(3):381-390. doi: 10.1016/j.eururo.2018.11.037. Epub 2018 Nov 30.
The Vescica Ileale Padovana (VIP) was first described in 1989 as a technique for total bladder replacement, and gained popularity due to technical simplicity and functional advantages.
To report preliminary results and a detailed step-by-step surgical technique description of robot-assisted VIP (ra-VIP) that replicates the open technique principles.
DESIGN, SETTING, AND PARTICIPANTS: We report the data of 15 consecutive patients who underwent robot-assisted radical cystectomy (RARC) and totally intracorporeal ra-VIP at our institution from April 2015 to March 2017.
RARC, extended pelvic lymph-node dissection, and totally intracorporeal ra-VIP. An enhanced recovery after surgery (ERAS) protocol was adopted in most cases.
Perioperative outcomes (operating time, blood loss, transfusion rate, and hospital stay), readmission for early (30d) and late (90d) postoperative complications, pathological and oncological outcomes, and overall/cancer-specific survival were reported.
The median (interquartile range) age was 60 (54-66)yr. The median body mass index was 24 (24-25). The median American Society of Anesthesiologists score was 2 (2-2). The operative time was 390 (284-470)min and the estimated blood loss was 300 (50-900) ml. No conversion to open technique was reported. The median hospital stay was 17 (12-23)d. Three patients received postoperative transfusions. Six patients had 90-d major complications. One patient was readmitted after discharge and reported a long-term sequela. One positive margin was reported. At a mean follow-up of 17 (13-25)mo, 14 (93%) patients were alive: one patient died from disease progression. Daytime continence rate at 12mo was 62%.
Our preliminary results showed that ra-VIP appears to be a feasible technique for robot-assisted totally intracorporeal bladder replacement following robotic radical cystectomy.
Vescica Ileale Padovana (VIP) was first described almost 30yr ago for bladder replacement after radical cystectomy. We report a step-by-step technique of robot-assisted VIP that follows the open surgical principles of detubularization and double folding, mixing the advantages of VIP with the benefits of the robotic approach.
帕多瓦回肠膀胱术(VIP)于 1989 年首次被描述为一种全膀胱替代技术,由于技术简单和功能优势而广受欢迎。
报告机器人辅助 VIP(ra-VIP)的初步结果和详细的分步手术技术描述,该技术复制了开放技术的原则。
设计、环境和参与者:我们报告了 15 例连续患者的数据,他们于 2015 年 4 月至 2017 年 3 月在我们机构接受了机器人辅助根治性膀胱切除术(RARC)和完全腔内 ra-VIP。
RARC、扩大的盆腔淋巴结清扫术和完全腔内 ra-VIP。在大多数情况下采用了术后快速康复(ERAS)方案。
围手术期结果(手术时间、失血量、输血率和住院时间)、早期(30d)和晚期(90d)术后并发症的再入院率、病理和肿瘤学结果以及总/癌症特异性生存率。
中位(四分位间距)年龄为 60(54-66)岁。中位体重指数为 24(24-25)。中位美国麻醉医师协会评分 2(2-2)。手术时间为 390(284-470)min,估计失血量为 300(50-900)ml。无转为开放技术。中位住院时间为 17(12-23)天。3 名患者接受术后输血。6 例患者 90d 后出现严重并发症。1 例患者出院后再次入院,报告长期后遗症。1 例切缘阳性。在平均随访 17(13-25)mo 后,14 例(93%)患者存活:1 例患者死于疾病进展。12 个月时日间控尿率为 62%。
我们的初步结果表明,ra-VIP 似乎是一种可行的技术,可用于机器人辅助根治性膀胱切除术后的完全腔内膀胱替代。
Vescica Ileale Padovana(VIP)在 30 年前首次被描述用于根治性膀胱切除术后的膀胱替代。我们报告了一种分步机器人辅助 VIP 技术,该技术遵循去管和双折叠的开放手术原则,将 VIP 的优势与机器人方法的优势相结合。